Carlson Capital L P Mei Pharma, Inc. Transaction History

Carlson Capital L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $0.35 $193,200 - $322,000	920,000 Added 77.97%	2,100,000 $483,000
Q4 2022 Feb 14, 2023	BUY	$0.22 - $0.41 $6,600 - $12,300	30,000 Added 2.61%	1,180,000 $283,000
Q3 2022 Nov 14, 2022	BUY	$0.41 - $0.64 $20,500 - $32,000	50,000 Added 4.55%	1,150,000 $445,000
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $243,600 - $377,000	580,000 Added 111.54%	1,100,000 $666,000
Q1 2022 May 13, 2022	BUY	$0.54 - $2.74 $178,200 - $904,200	330,000 Added 173.68%	520,000 $313,000

Q4 2021 Feb 11, 2022	BUY	$2.33 - $3.37 $442,700 - $640,300	190,000 New	190,000 $507,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.